Thomas C. Merigan

Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferon.

T. Merigan, W. Seaman, N. Talal, 1979, Journal of immunology.

Suppressive effect of interferon on the humoral immune response to sheep red blood cells in mice.

T. Merigan, B. Brodeur, Thomas C. Merigan, 1974, Journal of immunology.

Lymphocyte interferon production and transformation after Herpes simplex infections in humans.

T. Merigan, D. Stevens, L. Rasmussen, 1974, Journal of immunology.

A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients.

M. Shapero, T. Merigan, E. Engleman, 1998, AIDS research and human retroviruses.

Mechanism of the suppressive effect of interferon on antibody synthesis in vivo.

T. Merigan, B. Brodeur, Thomas C. Merigan, 1975, Journal of Immunology.

Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune disease.

T. Merigan, H. Mcdevitt, E. Engleman, 1981, Arthritis and rheumatism.

Time and dosage dependence of immunoenhancement by murine type II interferon preparations.

T. Merigan, G. Sonnenfeld, A. Mandel, 1978, Cellular immunology.